Cargando…

Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG

PURPOSE: RE-PERG is altered in presence of primary neuronal degeneration of retinal ganglion cells, both in glaucoma and other diseases. A previous study showed that in a model of retrograde degeneration (vascular dementia) RE-PERG was normal. In this study, we enrolled patients with pituitary adeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Mavilio, Alberto, Sisto, Dario, Dammacco, Rosanna, Durante, Giuseppe, Alessio, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759009/
https://www.ncbi.nlm.nih.gov/pubmed/36536926
http://dx.doi.org/10.2147/OPTH.S384525
_version_ 1784852160231505920
author Mavilio, Alberto
Sisto, Dario
Dammacco, Rosanna
Durante, Giuseppe
Alessio, Giovanni
author_facet Mavilio, Alberto
Sisto, Dario
Dammacco, Rosanna
Durante, Giuseppe
Alessio, Giovanni
author_sort Mavilio, Alberto
collection PubMed
description PURPOSE: RE-PERG is altered in presence of primary neuronal degeneration of retinal ganglion cells, both in glaucoma and other diseases. A previous study showed that in a model of retrograde degeneration (vascular dementia) RE-PERG was normal. In this study, we enrolled patients with pituitary adenoma (PA) to evaluate RE-PERG findings in another model of retrograde degeneration compared with healthy controls (HC). Based on the outcome of the present and our previous studies with RE-PERG, and reviewing the literature, we discuss the physiopathology of glaucoma. METHODS: Twelve PA patients and 14 age-matched HC were recruited. All participants performed visual field (VF) test, retinal nerve fiber layer (RNFL) and ganglion cells complex (GCC) thickness measurement by means of optical coherence tomography (OCT), visual evoked potentials (VEPs) and RE-PERG, a non-invasive, fast steady-state pattern electroretinogram (SS-PERG) sampled in five consecutive blocks of 130 events. RESULTS: VEPs amplitude was significantly lower in PA with respect to HC (6.8±0.6 vs 7.4±0.6 µV; p=0.045). VEPs latency was higher in PA (123.2±5.8 vs 103.6±4.1 msec; p<0.01). As for VF, mean defect (MD) and pattern standard deviation (PSD) were higher in PA (−6.6±2.6 vs −0.01±1.02 dB; p<0.01 and 8.5±3.1 vs 1.5±0.3; p<0.01, respectively). RNFL thickness was lower in PA (88±8.1 vs 97±9.3 µ; p=0.01). There was no statistically significant difference between PA and HC for RE-PERG. There was a significant correlation among MD, PSD, VEPs amplitude, PERG amplitude and RNFL thickness in the PA group, whereas no correlation was found with SDPh, which remains as normal as in the HC group. CONCLUSION: Our findings confirm that RE-PERG is not altered in retrograde degeneration. Based on the outcome of the present and our previous studies about RE-PERG and glaucoma, we assume that in glaucoma a double mechanism of retinal ganglion cells degeneration, both retrograde and primary, can coexist.
format Online
Article
Text
id pubmed-9759009
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97590092022-12-18 Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG Mavilio, Alberto Sisto, Dario Dammacco, Rosanna Durante, Giuseppe Alessio, Giovanni Clin Ophthalmol Original Research PURPOSE: RE-PERG is altered in presence of primary neuronal degeneration of retinal ganglion cells, both in glaucoma and other diseases. A previous study showed that in a model of retrograde degeneration (vascular dementia) RE-PERG was normal. In this study, we enrolled patients with pituitary adenoma (PA) to evaluate RE-PERG findings in another model of retrograde degeneration compared with healthy controls (HC). Based on the outcome of the present and our previous studies with RE-PERG, and reviewing the literature, we discuss the physiopathology of glaucoma. METHODS: Twelve PA patients and 14 age-matched HC were recruited. All participants performed visual field (VF) test, retinal nerve fiber layer (RNFL) and ganglion cells complex (GCC) thickness measurement by means of optical coherence tomography (OCT), visual evoked potentials (VEPs) and RE-PERG, a non-invasive, fast steady-state pattern electroretinogram (SS-PERG) sampled in five consecutive blocks of 130 events. RESULTS: VEPs amplitude was significantly lower in PA with respect to HC (6.8±0.6 vs 7.4±0.6 µV; p=0.045). VEPs latency was higher in PA (123.2±5.8 vs 103.6±4.1 msec; p<0.01). As for VF, mean defect (MD) and pattern standard deviation (PSD) were higher in PA (−6.6±2.6 vs −0.01±1.02 dB; p<0.01 and 8.5±3.1 vs 1.5±0.3; p<0.01, respectively). RNFL thickness was lower in PA (88±8.1 vs 97±9.3 µ; p=0.01). There was no statistically significant difference between PA and HC for RE-PERG. There was a significant correlation among MD, PSD, VEPs amplitude, PERG amplitude and RNFL thickness in the PA group, whereas no correlation was found with SDPh, which remains as normal as in the HC group. CONCLUSION: Our findings confirm that RE-PERG is not altered in retrograde degeneration. Based on the outcome of the present and our previous studies about RE-PERG and glaucoma, we assume that in glaucoma a double mechanism of retinal ganglion cells degeneration, both retrograde and primary, can coexist. Dove 2022-12-13 /pmc/articles/PMC9759009/ /pubmed/36536926 http://dx.doi.org/10.2147/OPTH.S384525 Text en © 2022 Mavilio et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Mavilio, Alberto
Sisto, Dario
Dammacco, Rosanna
Durante, Giuseppe
Alessio, Giovanni
Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title_full Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title_fullStr Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title_full_unstemmed Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title_short Retrograde Optic Nerve Degeneration in Pituitary Adenoma: A Study with RE-PERG
title_sort retrograde optic nerve degeneration in pituitary adenoma: a study with re-perg
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759009/
https://www.ncbi.nlm.nih.gov/pubmed/36536926
http://dx.doi.org/10.2147/OPTH.S384525
work_keys_str_mv AT mavilioalberto retrogradeopticnervedegenerationinpituitaryadenomaastudywithreperg
AT sistodario retrogradeopticnervedegenerationinpituitaryadenomaastudywithreperg
AT dammaccorosanna retrogradeopticnervedegenerationinpituitaryadenomaastudywithreperg
AT durantegiuseppe retrogradeopticnervedegenerationinpituitaryadenomaastudywithreperg
AT alessiogiovanni retrogradeopticnervedegenerationinpituitaryadenomaastudywithreperg